I put no value right now in enta Covid drug personally

I added more shares today at $9.7538.

So why Ibuzatrelvir would go P3 but EDP-235 is having such difficulty finding regulatory pathway to P3?

In my prior post, I was refrrring to the examination of ENTA's RSV data (under an NDA) that PFE could conceivably be doing as a prelude to a buyout offer.

In any case RFK seems to be focusing on NIH (where HHS does have more control - eg hiring and firing the director), not FDA.

I don’t see RFK Jr. getting confirmed as Sec of HHS. And If he is placed as HHS lead, his initiatives would be reduced by the medical community.

Why wouldn't PFE want to talk up a company they would be buying?

I wonder how many Americans know who the current Secretary of HHS is ?

Next to zip

Yes, this is a common scenario. PFE would have to sign a non-disclosure agreement and would have to restrict the data examination to a specified small group of employees.

The exciting time is here. Any day from now, we will know about

IMO, the company is entering an extended period of wandering through a relatively catalyst free desert (absent a buyout/partnership).

Any specific reason VKTX drop today?

Tender offer delayed until 11/19/24 (or later):

Foley doesn't have to agree to a lower price (but he's stupid so who knows what he'll do).

You are missing 2025 financial forecasts.

I do think there is a debate about weather Viking can make VK2735 at scale competitively cause its a peptide large molecule. I'm going to repeat my earlier investment thesis on this point which is basically Brian Lian is not an idiot. He has a PhD in Organic Chemistry,, has a great business sense and would not waste resources on something that wasn't going to be competitive. ( He's also got 930 Million in the bank.)

Vin & Marthambles- Yes I did expect volatility today but not this extreme.

VKTX has a major event at Obesity Week on Sunday at 7:30 PM where they will disclose info VK2735 on the oral doses up to 100mg (only disclosed up to 40mg QD so far) and data from the Subq phase 2 Venture study (minimally expect more pK data plus lipids info). Expect volatility today and especially on Monday.

been around the markets for 50+ years, worked on wall st., ( IB and completed 2 R/M's) and this one is pretty unique

Tender offer delayed until Nov 12 (or later):

Still mind boggling we're talking about a buyout price of $6.66, but, such is life.

It'll be interesting to see how Crown looks at it from the financial standpoint.

There is no chance the offer price will go down, IMO, mostly because of the aforementioned. If anything, it could be nudged up.

I can't speak for anyone else but as for myself, I never heard of CLF. I own ENTA and made money a while ago after their HepC success as I bought in the $30s and $40 and sold some over $100. I believed in their Covid drug and lost some back but still have high hopes.

What happened to that Meteoric guy who was constantly spewing derisions at everyone.

Those individuals who advised the shareholders to hold their shares until it closes ( you know who you are) have once again have given poor advice.

Just look at CLF, ENTA AND RVNC. How has that worked for you ??

One or two usually trusted posters seem to be encouraging Revance holders not to sell their shares without making them aware of any of the risk. I don’t care whether somebody holds their shares. I would like them to be aware that a substantial risk is involved in holding them.

People with superior investing skill, and knowledge seem to be quite willing to take advantage of those who have less skill and less knowledge. I would like to reduce the probability of that happening.

Short interest increased 15% to 3.4M shares
as of 15 Oct vs 30 Sep., the highest short interest for 2024 to date.

We do not have enough information to know which party might pay a break fee. … Or if they will just agree to walk away. But If the deal fails, the price will almost certainly fall below $2.50 almost immediately. …. And trend towards a dollar.

Fun to see how Foley messes up even a lowball offer

I have never seen anything like that before.

Can’t wait to see him get terminated

My experience… nothing is certain in the market, especially in biotech.

board is too quiet for this 65-75 move

Interesting dumping with light volume and so far no news yet